249 related articles for article (PubMed ID: 14720455)
1. New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments.
Lieber CS
Curr Gastroenterol Rep; 2004 Feb; 6(1):60-5. PubMed ID: 14720455
[TBL] [Abstract][Full Text] [Related]
2. Alcoholic liver disease: new insights in pathogenesis lead to new treatments.
Lieber CS
J Hepatol; 2000; 32(1 Suppl):113-28. PubMed ID: 10728799
[TBL] [Abstract][Full Text] [Related]
3. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases.
Lieber CS
Adv Pharmacol; 1997; 38():601-28. PubMed ID: 8895826
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis and treatment of alcoholic liver disease: progress over the last 50 years.
Lieber CS
Rocz Akad Med Bialymst; 2005; 50():7-20. PubMed ID: 16363067
[TBL] [Abstract][Full Text] [Related]
5. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.
Lieber CS
Alcohol; 2004 Aug; 34(1):9-19. PubMed ID: 15670660
[TBL] [Abstract][Full Text] [Related]
6. ALCOHOL: its metabolism and interaction with nutrients.
Lieber CS
Annu Rev Nutr; 2000; 20():395-430. PubMed ID: 10940340
[TBL] [Abstract][Full Text] [Related]
7. Treatment of alcoholic liver disease.
Day CP
Liver Transpl; 2007 Nov; 13(11 Suppl 2):S69-75. PubMed ID: 17969070
[TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with alcoholic liver disease.
Zhang FK; Zhang JY; Jia JD
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):12-7. PubMed ID: 15730911
[TBL] [Abstract][Full Text] [Related]
9. Liver diseases by alcohol and hepatitis C: early detection and new insights in pathogenesis lead to improved treatment.
Lieber CS
Am J Addict; 2001; 10(s1):s29-s50. PubMed ID: 11268819
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and therapy of alcoholic liver disease.
Levitsky J; Mailliard ME
Semin Liver Dis; 2004 Aug; 24(3):233-47. PubMed ID: 15349802
[TBL] [Abstract][Full Text] [Related]
11. S-Adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings.
Lieber CS
Alcohol; 2002 Jul; 27(3):173-7. PubMed ID: 12163146
[TBL] [Abstract][Full Text] [Related]
12. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
[TBL] [Abstract][Full Text] [Related]
13. Advances in alcoholic liver disease.
Song Z; Joshi-Barve S; Barve S; McClain CJ
Curr Gastroenterol Rep; 2004 Feb; 6(1):71-6. PubMed ID: 14720457
[TBL] [Abstract][Full Text] [Related]
14. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium.
Purohit V; Russo D; Coates PM
Alcohol; 2004 Aug; 34(1):3-8. PubMed ID: 15670659
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and treatment of liver fibrosis in alcoholics: 1996 update.
Lieber CS
Dig Dis; 1997; 15(1-2):42-66. PubMed ID: 9101129
[TBL] [Abstract][Full Text] [Related]
16. Long-term management of alcoholic liver disease.
Wakim-Fleming J; Mullen KD
Clin Liver Dis; 2005 Feb; 9(1):135-49. PubMed ID: 15763233
[TBL] [Abstract][Full Text] [Related]
17. Review article: current management of alcoholic liver disease.
Tome S; Lucey MR
Aliment Pharmacol Ther; 2004 Apr; 19(7):707-14. PubMed ID: 15043511
[TBL] [Abstract][Full Text] [Related]
18. S-adenosyl-L-methionine: its role in the treatment of liver disorders.
Lieber CS
Am J Clin Nutr; 2002 Nov; 76(5):1183S-7S. PubMed ID: 12418503
[TBL] [Abstract][Full Text] [Related]
19. Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon.
Lieber CS; Leo MA; Aleynik SI; Aleynik MK; DeCarli LM
Alcohol Clin Exp Res; 1997 Apr; 21(2):375-9. PubMed ID: 9113278
[TBL] [Abstract][Full Text] [Related]
20. [New suggestions for the management of alcoholic liver diseases].
Jmelnitzky AC
Acta Gastroenterol Latinoam; 1995; 25(2):73-84. PubMed ID: 8525763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
